NCT01958008 BI 113608 Administered as Tablets Twice Daily Over 4 Weeks in Patients With Chronic Obstructive Pulmonary Disease Associated With Chronic Bronchitis Status COMPLETED Phase PHASE1
NCT01957657 Pharmacokinetics, Safety and Tolerability of the Combination of BI 207127 and Faldaprevir in Renal Impaired Patients Status TERMINATED Phase PHASE1
NCT01957644 Phase I Dose Escalation Trial of Volasertib in Combination With Azacitidine in Patients With MDS or CMML Status TERMINATED Phase PHASE1
NCT01955733 Safety and Efficacy of BI 695500 in Patients With Moderately to Severely Active Rheumatoid Arthritis Status TERMINATED Phase PHASE3
NCT01955720 Safety, Tolerability, PK and PD of BI 655075 and Establishment of BI 655075 Dose(s) Effective to Reverse Prolongation of Blood Coagulation Time by Dabigatran Status COMPLETED Phase PHASE1
NCT01953913 Afatinib (BIBW 2992) in Advanced Non-Small Cell Lung Cancer Patients With EGFR Mutation Status COMPLETED Phase PHASE3
NCT01951846 To Determine the Maximum Tolerated Dose (MTD) of BIBF 1120 in Patients With Solid Tumours Status COMPLETED Phase PHASE1
NCT01950273 Pharmacokinetics and Pharmacodynamics of BI 695500 vs. Rituximab as First Line-treatment in Patients With Low Tumor Burden Follicular Lymphoma Status COMPLETED Phase PHASE1
NCT01948141 Nintedanib in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Up to Two Previous Chemotherapy Regimens Status COMPLETED Phase PHASE2
NCT01947855 Post Prandial Glucose (PPG) Study of Empagliflozin in Japanese Patients With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE3
NCT01947153 Two-way Crossover Study in Healthy Male and Female Subjects to Evaluate the Bioequivalence of Jentadueto®. Status COMPLETED Phase PHASE1
NCT01941615 Effect of BI 207127 + Faldaprevir on Blood Levels of Oral Contraceptives Containing Ethinylestradiol and Levonorgestrel Status TERMINATED Phase PHASE1
NCT01938846 BI 860585 Dose Escalation Single Agent and in Combination With Exemestane or With Paclitaxel in Patients With Various Advanced and/or Metastatic Solid Tumors Status COMPLETED Phase PHASE1
NCT01937390 Observational Study of Adherence to LABA / LAMA in Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase N/A
NCT01931306 Expanded Access Study of Afatinib in Treatment-naive or Chemotherapy Pre-treated Patients With Non-small Cell Lung Cancer (NSCLC) Status APPROVED_FOR_MARKETING Phase N/A
NCT01929044 Efficacy of Buscopan® in Comparison With 654-II (Anisodamine) in Acute Gastric or Intestinal Pain Status COMPLETED Phase PHASE3
NCT01929031 Efficacy and Safety of Ibuprofen and Caffeine in Dental Pain Status COMPLETED Phase PHASE3